IMS Solutions raises a £1.1m seed round led by Midlands Mindforge to develop steroid tests for cancer and PMOS

IMS Solutions develops diagnostic tests that analyse steroid metabolites in urine and blood using mass spectrometry and machine learning. IMS Solutions focuses on earlier and more accurate diagnosis of adrenocortical cancer and stratification of patients with polyendocrine metabolic ovarian syndrome.